Inactive Instrument

News Progenics Pharmaceuticals, Inc.

Stocks

US7431871067

Biotechnology & Medical Research

All News

20-06-22	PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-06-22	Progenics Pharmaceuticals, Inc. Announces Board Changes	CI
20-06-22	Progenics Pharmaceuticals, Inc. Announces Executive Changes	CI
20-06-22	Progenics Pharmaceuticals, Inc. Announces Executive Changes	CI
20-06-22	Progenics Pharmaceuticals, Inc. Appoints Robert J. Marshall Jr. as Treasurer	CI
20-06-22	Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics	BU
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Composite 1500	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 1000	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P TMI Index	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Global BMI Index	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600 Health Care	CI
20-06-22	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Biotechnology Select Industry Index	CI
20-06-17	PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
20-06-16	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20-06-16	Progenics Stockholders Approve Merger with Lantheus	GL
20-06-11	PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
20-06-08	PROGENICS PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
20-05-28	PROGENICS PHARMACEUTICALS INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	AQ
20-05-27	WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.	PR
20-05-19	Progenics Pharmaceuticals : to Present Results from the Phase 3 CONDOR Trial of PyL in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	AQ
20-05-18	PROGENICS PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
20-05-18	Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	GL
20-05-18	Progenics Pharmaceuticals, Inc. Announces Results from the Phase 3 Condor Trial of Pyl™	CI
20-05-08	Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceuticals, Inc.; Investors Are Encouraged To Contact The Firm	PR